FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT AND DISBURSEMENT LETTERLoan and Security Agreement and Disbursement Letter • March 1st, 2013 • Halozyme Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 1st, 2013 Company IndustryTHIS FIRST AMENDMENT to Loan and Security Agreement and Disbursement Letter (this “Amendment”) is entered into as of February 5, 2013, by and among OXFORD FINANCE LLC (“Oxford”) as collateral agent (in such capacity, the “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement or otherwise a party thereto from time to time including, without limitation, Oxford in its capacity as a Lender, and SILICON VALLEY BANK (in such capacity, each a “Lender” and collectively, the “Lenders”), and HALOZYME THERAPEUTICS, INC., a Delaware corporation, and HALOZYME, INC., a California corporation (individually and collectively, jointly and severally, “Borrower”).